Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Shenwu Capsule in Treating Amnestic Mild Cognitive Impairment

NCT01451749 is registered in ClinicalTrials.gov with North China Pharmaceutical Group Corporation as lead sponsor.

NCT NCT01451749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01451749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Shenwu Capsule in Treating Amnestic Mild Cognitive Impairment
Lead sponsor
North China Pharmaceutical Group Corporation
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
May 31, 2010
Enrollment
324 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment